Alexander K. Tsai
-
- CAR-T cell therapy research 7
- Cancer Immunotherapy and Biomarkers 4
-
- Immune Cell Function and Interaction 3
- Immunotherapy and Immune Responses 3
- Toxin Mechanisms and Immunotoxins 2
-
- Monoclonal and Polyclonal Antibodies Research 2
-
- Palliative Care and End-of-Life Issues 2
-
- Viral gastroenteritis research and epidemiology 1
- Co-authors
- Eduardo DávilaDaniel A. ValleraJohn R. OhlfestLucy Lu WangYuanyuan LiangNaomi Q. HansonMichael Y. TsaiAnne Blaes
- Cited by
- OncologyImmunologyHepatology
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Alexander K. Tsai
18 papers receiving 314 citations
Peers
Comparison fields: 5 of 71
- Oncology 103
- Immunology 71
- Hepatology 25
- Endocrinology 14
- Biotechnology 16
Countries citing papers authored by Alexander K. Tsai
This map shows the geographic impact of Alexander K. Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander K. Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander K. Tsai more than expected).
Fields of papers citing papers by Alexander K. Tsai
This network shows the impact of papers produced by Alexander K. Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander K. Tsai. The network helps show where Alexander K. Tsai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alexander K. Tsai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 21 | |
| 6 | 2024 | 4 | |
| 7 | 2023 | 17 | |
| 8 | 2023 | 22 | |
| 9 | 2023 | 1 | |
| 10 | 2017 | 12 | |
| 11 | 2017 | 36 | |
| 12 | 2017 | 0 | |
| 13 | 2016 | 16 | |
| 14 | 2013 | 19 | |
| 15 | 2011 | 6 | |
| 16 | 2011 | 25 | |
| 17 | 2010 | 30 | |
| 18 | 2010 | 14 | |
| 19 | 2009 | 19 | |
| 20 | 2007 | 44 |
About Alexander K. Tsai
Alexander K. Tsai is a scholar working on Oncology, Immunology and Occupational Therapy, having authored 23 papers that have together received 318 indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (4 papers), Immune Cell Function and Interaction (3 papers), Immunotherapy and Immune Responses (3 papers), Toxin Mechanisms and Immunotoxins (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Palliative Care and End-of-Life Issues (2 papers) and Viral gastroenteritis research and epidemiology (1 paper). The work is most often cited by research in Oncology (103 citations), Immunology (71 citations) and Hepatology (25 citations). Alexander K. Tsai has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Eduardo Dávila, Daniel A. Vallera, John R. Ohlfest, Lucy Lu Wang, Yuanyuan Liang, Naomi Q. Hanson, Michael Y. Tsai, Anne Blaes, Angela Panoskaltsis‐Mortari and Seunguk Oh. Their work appears in journals such as Atherosclerosis, The Oncologist, Cancer Immunology Research, Clinical Infectious Diseases and JCO Clinical Cancer Informatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.